Stockton Partners

What is Stockton Partners?

Stockton Partners is an investment fund that primarily focuses on mid to late-stage private companies. With a specific aim to deploy capital in fields that are related to health and technology, they seek opportunities within the medical device, life science enabling tools, biotechnology, pharmaceuticals, and health-tech sectors.

They offer companies not just financial resources but also strategic support, leveraging their expertise in the industry to steer these businesses towards growth and success. The fund has outlined clear investment parameters, with an investment minimum and maximum of $41,000,000, indicating a preference for substantial, singular investments that can make a significant impact on the future growth of the target companies.

Their investment thesis revolves around identifying companies that have the potential to disrupt the market with innovative solutions to healthcare challenges, tapping into the scalability of these technologies. Stockton Partners is involved in the full lifecycle of their investments, from the crucial stages of development through to the realization of value, with the goal of optimizing outcomes for both the fund and the companies they invest in.

They are strategic with their capital allocation, ensuring that they provide the necessary resources to help their portfolio companies achieve their full potential while navigating the complexities of the healthcare market.